Januvia and Pancreatic Cancer

If you or a loved one used Januvia and were later diagnosed with pancreatic cancer, you may be eligible to receive compensation. Januvia, a drug that is taken to treat Type II diabetes, has been specifically linked to increased risk of contracting certain types of cancer. Contact Carabin Shaw today if you or a loved one suffer from pancreatic cancer and used Januvia.

Januvia, a drug sold by Merck and Cosince, was originally approved by the Food and Drug Administration in 2006 for treatment of Type 2 Diabetes. Starting in 2011, and thereafter, several studies concluded that Januvia increased the risk of pancreatic cancer, as well as pancreatitis. Further research in 2013 concluded that Januvia and other name brand drugs, such as Janumet, Byetta, and Bydureon, were linked to pancreatic cancer and pancreatitis. Several studies have found that Januvia may raise the risk of pancreatic cancer by 2.7 fold and pancreatitis by at least 6 fold. The following are potential side effects:

• Pancreatic or Thyroid cancer
• Acute pancreatitis
• Hemorrhagic pancreatitis
• Necrotizing pancreatitis

We believe that the companies that sell these drugs should be held responsible. Those who have been affected by Januvia may be eligible for damages to include:

• Pain and suffering
• Medical expenses
• Cost of future care
• Lost wages
• Permanent injuries or disability
• Wrongful death of your loved one

Don’t let the companies that sold and manufactured these drugs get away with causing injury to you or your family Contact the lawyers at Carabin Shaw today.